Big news! We've been selected for the BioTools Innovator accelerator this year. Our team is making rapid progress, and we are so grateful for BTI's timely support and belief in our vision.
Anvil Diagnostics
Biotechnology Research
Cambridge, Massachusetts 341 followers
Rapid, scalable microbial diagnostics for precision medicine.
About us
Anvil is building efficient diagnostics for precision medicine. Our core technologies in rapid, scalable DNA detection will enable a new generation of accessible and routine diagnostics for the most complex conditions. Rather than building our own hardware platform from scratch, we develop unconventional statistically motivated assays to upgrade the capabilities of existing digital PCR systems. Follow us if you are passionate about bridging data science and molecular biology. We are first developing a rapid assay for critically ill patients that can broadly detect and quantify 100's of plausible pathogens and genetic markers directly from a blood sample. Today's diagnostics take days and often fail outright, and the lack of a rapid and reliable alternative forces clinicians to treat critically ill patients based on educated guesses. We envision a simple, routine test that consistently delivers actionable results and resolves clinical ambiguity.
- Website
-
www.anvildiagnostics.com
External link for Anvil Diagnostics
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
Get directions
Cambridge, Massachusetts, US
Updates
-
We are so grateful to have been selected to pitch at the BioTools Innovator Road Tour last week. For a full day, we received targeted feedback from curated, experienced judges. We are making fast progress on our core technology, and opportunities like this help us stress-test our vision and clarify the path ahead. Huge thanks BTI for hosting a great event!
-
-
We are excited to see leaders from bioMérieux, a major force in IVD and microbiology, recognize digital PCR as "the future technology for diagnostics" given its much higher sensitivity than standard qPCR. Several instrument developers have been launching digital PCR systems in the last few years. The latest Nio+ from Stilla Technologies boasts impressive analytical capabilities, a smaller form factor, and convenient workflows for busy labs. Congrats to Stilla on the new platform launch! At Anvil, we are building powerful, unconventional assays on digital PCR systems. The future is bright for this technology. https://lnkd.in/gFH57aV6
Nio™+ | digital PCR instrument - first installation at bioMérieux
https://www.youtube.com/
-
We are excited to see that the foundational Rice University research underpinning Anvil's technology was just published in Analytical Chemistry. This paper demonstrates how digital PCR and compressed sensing can be combined to efficiently differentiate many microbes with simple assays. Anvil is further developing interdisciplinary approaches like this for potent applications in clinical diagnostics and beyond. https://lnkd.in/eCWRyCDx
-
At Anvil, we are preparing to join the fight against antimicrobial resistance (AMR). Advancements in molecular microbial diagnostics will provide clinicians with results more quickly, allowing for better informed treatment plans. Reducing the use of ineffective antibiotics and monitoring infections with cutting-edge technologies will be critical to fostering antibiotic stewardship.
World Antimicrobial Awareness Week 2023
who.int
-
We're excited to welcome Aric Brown to the team as a Senior Scientist! Aric received his B.A. in cell/molecular biology and German from Washington & Jefferson College and his Ph.D. in microbiology and immunology from the University of Michigan. Through his dissertation, Aric studied bacterial growth kinetics and metabolic regulation in the context of Gram-negative bacteremia and is excited to bring this background to microbial diagnostics at Anvil.
-
-
Our existence is now LinkedIn official! We're excited to push forward our R&D towards a rapid diagnostic assay for sepsis. We're expanding and looking to hire experienced scientists. If you or someone you know is interested in interdisciplinary clinical diagnostics and would be excited to jump into a growing startup, please send them our way. #hiring